Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies

J Immunol. 2020 Apr 15;204(8):2308-2315. doi: 10.4049/jimmunol.1901396. Epub 2020 Mar 9.

Abstract

CRISPR/Cas9 technologies have revolutionized our understanding of gene function in complex biological settings, including T cell immunology. Current CRISPR-mediated gene editing strategies in T cells require in vitro stimulation or culture that can both preclude the study of unmanipulated naive T cells and alter subsequent differentiation. In this study, we demonstrate highly efficient gene editing within uncultured primary naive murine CD8+ T cells by electroporation of recombinant Cas9/sgRNA ribonucleoprotein immediately prior to in vivo adoptive transfer. Using this approach, we generated single and double gene knockout cells within multiple mouse infection models. Strikingly, gene deletion occurred even when the transferred cells were left in a naive state, suggesting that gene deletion occurs independent of T cell activation. Finally, we demonstrate that targeted mutations can be introduced into naive CD8+ T cells using CRISPR-based homology-directed repair. This protocol thus expands CRISPR-based gene editing approaches beyond models of robust T cell activation to encompass both naive T cell homeostasis and models of weak activation, such as tolerance and tumor models.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes / immunology*
  • CRISPR-Cas Systems / genetics*
  • CRISPR-Cas Systems / immunology
  • Clustered Regularly Interspaced Short Palindromic Repeats / genetics*
  • Clustered Regularly Interspaced Short Palindromic Repeats / immunology
  • Electroporation
  • Female
  • Gene Editing*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Polymorphism, Single Nucleotide / genetics
  • Polymorphism, Single Nucleotide / immunology